Here’s
an interesting article. It investigates how various medical specialists
coordinate anticoagulation bridging decisions for certain patients with atrial
fibrillation.
Long-term
anticoagulant therapy is essential for stroke prevention among patients with
atrial fibrillation, but increasing evidence also points to substantial risk
for adverse events, especially when anticoagulation is even only temporarily
interrupted.
A
recently published Effectiveness of Bridging Anticoagulation for Surgery Trial
confirmed prior observational evidence that using short-acting anticoagulants
periprocedurally increases bleeding risk without any reduction in stroke risk.
Little
is known about how medical specialists coordinate the complex decision of which
patients to bridge…
No comments:
Post a Comment